Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tamoxifen and hypertriglyceridemia.

G H Jonkers

    The Netherlands Journal of Medicine
    |September 4, 1999
    PubMed
    Summary

    A patient experienced severe hypertriglyceridemia, a dangerous increase in blood fats, while taking Tamoxifen and a statin. A fibrate medication effectively lowered these fat levels, addressing this serious side effect.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Foreword.

    Strabismus·2011
    Same author

    Short-segment jejunal stenosis complicating subacute portomesenteric venous thrombosis in a patient with protein S deficiency type II.

    The American journal of gastroenterology·1996
    Same author

    The determination of the central static visual acuity.

    Documenta ophthalmologica. Advances in ophthalmology·1992
    Same author

    The determination of the central static visual acuity, presentation of a modified Landolt C chart.

    Documenta ophthalmologica. Advances in ophthalmology·1991
    Same author

    President Kruger's eye disorder.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·1986
    Same author

    An energy-dependent corticosterone uptake system in the rat liver cell.

    FEBS letters·1980

    Area of Science:

    • Endocrinology
    • Pharmacology
    • Oncology

    Background:

    • Tamoxifen is a common endocrine therapy for breast cancer patients post-mastectomy.
    • Statins are widely prescribed for managing lipid disorders.
    • Hypertriglyceridemia is a condition characterized by excessively high levels of triglycerides in the blood.

    Observation:

    • A patient on Tamoxifen and a statin developed severe hypertriglyceridemia.
    • The co-administration of Tamoxifen and a statin may contribute to significant lipid level disturbances.
    • This adverse drug event highlights potential drug-drug interactions affecting lipid metabolism.

    Findings:

    • The study discusses the potential mechanisms behind Tamoxifen-induced hypertriglyceridemia.
    • Fibrates were investigated for their therapeutic efficacy in managing this condition.
    • Successful triglyceride reduction was observed with fibrate therapy.

    Implications:

    • This case underscores the importance of monitoring lipid profiles in patients receiving Tamoxifen and statins.
    • Fibrates may represent a viable treatment option for managing severe hypertriglyceridemia in this clinical context.
    • Further research into drug interactions between endocrine therapies and lipid-lowering agents is warranted.

    Related Experiment Videos